CervoMed (CRVO) director Boger sold 36 shares

Insider transactions reported

Joshua S Boger (director at CervoMed Inc., CRVO) reported that they sold 36 shares, and acquired 495,995 shares on Feb 26, 2024. After these transactions the filing shows 840,451 shares held indirectly (By Trusts).

Reporting person

Boger Joshua S

Options and other derivatives

Holdings before and after

• Common Stock: 344,492 to 840,451 indirect, By Trusts
• Pre-Funded Common Stock Purchase Warrant: 495,995 to 0 indirect, By Trusts

Other positions listed

• Common Stock: 216,817 direct

Footnotes from the filing

1. 1. On February 26, 2024, a pre-funded common stock purchase warrant to purchase 495,995 shares of the Issuer's common stock (as amended, the Pre-Funded Warrant ) held by the JSB 2021 Trust (as defined below) was amended and subsequently exercised in full on a cashless basis. In accordance with the terms of the Pre-Funded Warrant, 36 shares of the Issuer's common stock were withheld in lieu of a cash payment of the exercise price and the JSB 2021 Trust was issued the remaining 495,959 shares of the Issuer's common stock.
2. 2. After giving effect to all transactions described herein, consists of (i) 644,703 shares of the Issuer's common stock held by The Joshua S. Boger 2021 Trust DTD 12/09/2021 (the JSB 2021 Trust ) and (ii) 195,748 shares of the Issuer's common stock held by The Amy S. Boger 2021 Trust (the ASB 2021 Trust ). The Reporting Person serves as the sole trustee of each of the JSB 2021 Trust and the ASB 2021 Trust. The Reporting Person disclaims beneficial ownership of these securities, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of such securities for purposes of Section 16 or for any other purpose.
3. 3. Consists of shares of the Issuer's common stock underlying the previously issued Pre-Funded Warrant. The Pre-Funded Warrant is exercisable at any time after the date of issuance and the pre-funded warrants do not expire.

Transaction codes in this filing

Open-market sale:

Code S marks a sale in the open market or a private deal. The insider received cash for these securities.

Exercise of an in-the-money derivative:

Code X marks the exercise of a derivative that was in or at the money.

FAQ